Recent phase 2a findings on PORT-77 show rapid, dose-dependent plasma PPIX reductions in erythropoietic protoporphyria and X-linked protoporphyria.
Robert Sarkany, MD FRCP
Advertisement
Robert Sarkany, MD, FRCP, is a consultant dermatologist at St John's Institute of Dermatology at Guy's and St Thomas' Hospital in London and at the Lister Hospital.
Articles by Robert Sarkany, MD FRCP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
New Patch Pump Options Highlighted at ADCES 2026
2
Q&A: First Pediatric Eczema Guidelines and New Topical Options Down to Age 2
3
New Nonsteroidal Options Expand for Pediatric Atopic Dermatitis
4
Age-Specific Criteria Improve Anaphylaxis Detection in Infants
5